Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age
NCT00492544
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Papillomavirus
Interventions
BIOLOGICAL:
Cervarix™ (HPV-16/18 L1 VLP AS04)
Sponsor
GlaxoSmithKline